Doctors say RFK Jr.'s anti-Ozempic stance perpetuates stigma and misrepresents evidence [CNN]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: CNN
Robert F. Kennedy Jr. has pledged to tackle high rates of chronic diseases such as diabetes and obesity as President-elect Donald Trump's pick to lead the US Department of Health and Human Services. They're goals that many in the public health world find themselves agreeing with — despite fearing what else the infamous anti-vaccine activist may do in the post. Just don't suggest that he tackle those goals with medications like Ozempic. “They're counting on selling it to Americans because we're so stupid and so addicted to drugs,” Kennedy said in an appearance with Fox News' Greg Gutfeld that he posted to Instagram last month, concluding that Ozempic, a wildly popular medicine approved to treat type 2 diabetes and used off-label for weight loss, is not going to “Make America Healthy Again.” Kennedy claimed that Novo Nordisk, which makes Ozempic, doesn't market the medicine in its home country of Denmark, where “they do not recommend it for diabetes or obesity; they recommend die
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk's Wegovy launches in China, offering obesity drug at a fraction of US prices [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop [Yahoo! Finance]Yahoo! Finance
- Useless Europe is sleepwalking into oblivion [Yahoo! Finance]Yahoo! Finance
- Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says [Yahoo! Finance]Yahoo! Finance
- Weight loss drug makers still have huge upside, and the market overreacted to RFK Jr. named to top health role, BMO says [Business Insider]Business Insider
NVO
Earnings
- 11/7/24 - Beat
NVO
Sec Filings
- 11/19/24 - Form 6-K
- 11/18/24 - Form 6-K
- 11/14/24 - Form 6-K
- NVO's page on the SEC website